Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Physiologically-Based Parmacokinetic Model For Trichloroethylene Considering Enterohepatic Recirculation of Major Metabolites

Journal Article · · Risk Analysis
 [1];  [2];  [3];  [4]
  1. BATTELLE (PACIFIC NW LAB)
  2. Washington State University Tri-Cities
  3. .
  4. SELF-EMPLOYED CONSULTANTS

Trichloroacetic acid (TCA) is a major metabolite of trichloroethylene (TRI) thought to contribute to its hepatocarcinogenic effects in mice. Recent studies have shown that peak blood concentrations of TCA in rats do not occur until approximately twelve hours following an oral dose of TRI. However, blood concentrations of TRI reach a maximum within an hour and are non-detectable after two hours (1). The results of a study which examined the enterohepatic recirculation (EHC) of the principle TRI metabolites (2) was used to develop a physiologically-based pharmacokinetic model for TRI, which includes enterohepatic recirculation of its metabolites. The model quantitatively predicts the uptake, distribution and elimination of TRI, trichloroethanol, trichloroethanol-glucuronide, and TCA and includes production of metabolites through the enterohepatic recirculation pathway. Physiologic parameters used in the model were obtained from the literature (3 & 4). Parameters for TRI metabolism were taken from Fisher et al. (5). Other kinetic parameters were found in the literature or estimated from experimental data (2). The model was calibrated to data from experiments of an earlier study where TRI was orally administered (2). Verification of the model was conducted using data on the enterohepatic recirculation of TCEOH and TCA (2), chloral hydrate data (infusion doses) from Merdink (6), and TRI data from Templin (1) and Larson and Bull (7).

Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-76RL01830
OSTI ID:
1601807
Report Number(s):
PNWD-SA-4670
Journal Information:
Risk Analysis, Journal Name: Risk Analysis Journal Issue: 3 Vol. 18; ISSN 0272-4332
Publisher:
Wiley
Country of Publication:
United States
Language:
English

References (8)

Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate journal September 1990
Man versus Beast: Pharmacokinetic Scaling in Mammals journal November 1986
Factors affecting species differences in the kinetics of metabolites of trichloroethylene journal April 1995
The Groundwater Supply Survey journal May 1984
The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver journal September 1987
A Partition Coefficient Determination Method for Nonvolatile Chemicals in Biological Tissues journal May 1994
Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate journal August 1992
Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse journal June 1991

Similar Records

Physiologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites
Journal Article · Mon Jun 01 00:00:00 EDT 1998 · Risk Analysis · OSTI ID:642332

Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene.
Journal Article · Thu May 01 00:00:00 EDT 1997 · Drug Metabolism and Disposition · OSTI ID:1728618

Effect of enterohepatic circulation on the pharmacokinetics of chloral hydrate and its metabolites in F344 rats
Journal Article · Fri Jul 09 00:00:00 EDT 1999 · Journal of Toxicology and Environmental Health · OSTI ID:6474309

Related Subjects